Prospect Biosystems develops bioanalytical instrumentation, reagents, and biomarker evaluation and validation platforms. Prospect also provides biomarker evaluation and extensive proteomics services. Prospect’s products and technologies accelerate life science research, pharmaceutical product development, diagnostics, and surgical pathology.

The Company markets and distributes its products and services directly and through distributors and agents worldwide.

Prospect Biosystems was founded in 2006. Its office and laboratory are located at Enterprise Development Center in Newark, NJ. It is on the campus of New Jersey Institute of Technology.